INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 103 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 740 | -3.3% | 0.00% | – |
| Q3 2019 | $0 | – | 765 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 765 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $4,000 | +33.3% | 765 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $3,000 | -62.5% | 765 | 0.0% | 0.00% | -66.7% |
| Q3 2018 | $8,000 | +33.3% | 765 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $6,000 | +50.0% | 765 | +3.4% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -42.9% | 740 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $7,000 | 0.0% | 740 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | -22.2% | 740 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $9,000 | +12.5% | 740 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | +14.3% | 740 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $7,000 | -22.2% | 740 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $9,000 | – | 740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
| Front Row Advisors LLC | 60 | $0 | 0.00% |
| Executive Wealth Management, LLC | 20 | $0 | 0.00% |
| BARCLAYS PLC | 1,300 | $0 | 0.00% |
| BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
| Vectors Research Management, LLC | 505 | $0 | 0.00% |